- Home
- CASI vs MOVE Comparison
CASI vs MOVE Comparison
Compare CASI & MOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CASI | MOVE |
|---|---|---|
| Founded | 1991 | 2018 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7M | 15.9M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CASI | MOVE |
|---|---|---|
| Price | $0.82 | $11.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 26.1K | ★ 2.6M |
| Earning Date | 03-30-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $26,846,000.00 | $500,000.00 |
| Revenue This Year | N/A | $1,460.71 |
| Revenue Next Year | N/A | $96.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.72 | N/A |
| 52 Week Low | $0.74 | $4.67 |
| 52 Week High | $3.09 | $54.40 |
Technical Indicators
Market Signals| Indicator | CASI | MOVE |
|---|---|---|
| Relative Strength Index (RSI) | 38.96 | 46.08 |
| Support Level | $0.74 | $12.68 |
| Resistance Level | $0.97 | $16.25 |
| Average True Range (ATR) | 0.09 | 2.04 |
| MACD | -0.02 | -0.59 |
| Stochastic Oscillator | 19.74 | 8.25 |
Price Performance
Historical ComparisonAbout CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About MOVE Movano Inc.
Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.